Cody Eslinger

12PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsImmunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 11, 2026
Efficacy and safety of modified FLOT chemotherapy in gastric or gastroesophageal junction adenocarcinoma: a retrospective cohort study.

|Apr 03, 2026
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer.

Daniel Walden, Felipe Batalini, Cody Eslinger

|Apr 02, 2026
Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.

Cody Eslinger, Mohamad Bassam Sonbol, Ben George

|Nov 22, 2025
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 study.

Cody Eslinger, Daniel Walden, Alexandra Krivonos

|Nov 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo Clinic.

Oudai Sahwan, Fares Jamal, Rish Pai

|Feb 11, 2025
Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy.

Cody Eslinger, Daniel Walden, Alyssa McGary

Pageof 2

Frequent Collaborators

6 joint publications

Mohamad Bassam Sonbol

4 joint publications

Daniel Ahn

3 joint publications

Tanios Bekaii-Saab

2 joint publications

Balakrishna Koneru